These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2208080)

  • 1. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of bioavailability of dichlorobenzidine form diarylide azo pigments: molecular dosimetry for hemoglobin and DNA adducts.
    Sagelsdorff P; Haenggi R; Heuberger B; Joppich-Kuhn R; Jung R; Weideli HJ; Joppich M
    Carcinogenesis; 1996 Mar; 17(3):507-14. PubMed ID: 8631137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.
    Ghosal A; Iba MM
    Mutat Res; 1992 Jan; 278(1):31-41. PubMed ID: 1370117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent interaction of 3,3'-dichlorobenzidine with hepatic lipids. Enzymic basis and stability of the adducts.
    Iba MM; Lang B; Thomas PE; Ghosal A
    Biochem Pharmacol; 1990 Aug; 40(3):581-7. PubMed ID: 2116801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary monitoring method of 3,3'-dichlorobenzidine (DCB) and its metabolites, N-acetyl-DCB and N,N'-diacetyl-DCB.
    Lee JH; Shin HS; Jung DG; Lee YS
    Ind Health; 2003 Jul; 41(3):242-8. PubMed ID: 12916755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-induced mutagenicity in Salmonella TA102 and genotoxicity/cytotoxicity in human T-cells by 3,3'-dichlorobenzidine: a chemical used in the manufacture of dyes and pigments and in tattoo inks.
    Wang L; Yan J; Hardy W; Mosley C; Wang S; Yu H
    Toxicology; 2005 Feb; 207(3):411-8. PubMed ID: 15664269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1994; 68(1):8-14. PubMed ID: 8166610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of dichlorobenzidine-hemoglobin adducts by GC/MS-NCI.
    Joppich-Kuhn R; Hänggi R; Sagelsdorff P; Smith AE; Weideli HJ; Joppich M
    Int Arch Occup Environ Health; 1997; 69(4):240-6. PubMed ID: 9137997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of 3,3'-dichlorobenzidine in rat liver microsomes to mutagens: involvement of cytochrome P-450d.
    Iba MM; Thomas PE
    Carcinogenesis; 1988 May; 9(5):717-23. PubMed ID: 3130202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of hemoglobin adducts formed in rats exposed orally with 3,3'-dichlorobenzidine by GC/MS-SIM.
    Lee JH; Shin HS
    Toxicol Ind Health; 2002 May; 18(4):191-9. PubMed ID: 12974542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 3,3'-dichlorobenzidine to DNA and polyribonucleotides in vitro.
    Bratcher SC; Sikka HC
    Chem Biol Interact; 1982 Feb; 38(3):369-75. PubMed ID: 7060216
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of possible metabolism of pigment yellow 17, a 3,3'-dichlorobenzidine-based pigment, after inhalation exposure in rats.
    Hofmann T; Schmidt D
    Arch Toxicol; 1993; 67(2):141-4. PubMed ID: 8481102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidative activation of 3,3'-dichlorobenzidine to mutagenic products in the Salmonella typhimurium test.
    Lang B; Iba MM
    Mutat Res; 1987; 191(3-4):139-43. PubMed ID: 3306365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
    Gentile JM; Brown S; Aardema M; Clark D; Blankespoor H
    Arch Environ Health; 1985; 40(1):5-12. PubMed ID: 3922319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and urinary bladder tumors in dogs from 3,3'-dichlorobenzidine.
    Stula EF; Barnes JR; Sherman H; Reinhardt CF; Zapp JA
    J Environ Pathol Toxicol; 1978; 1(4):475-90. PubMed ID: 722199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of 3,3'-dichlorobenzidine in the rat.
    Hsu RS; Sikka HC
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):306-16. PubMed ID: 7123557
    [No Abstract]   [Full Text] [Related]  

  • 19. Transport behavior of 3,3'-dichlorobenzidine in a freshwater estuary.
    Nyman MC; McCord K; Wood WL; Blatchley ER
    Environ Toxicol Chem; 2003 Jan; 22(1):20-5. PubMed ID: 12503742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa.
    Imaoka S; Yoneda Y; Matsuda T; Degawa M; Fukushima S; Funae Y
    Biochem Pharmacol; 1997 Sep; 54(6):677-83. PubMed ID: 9310344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.